Information regarding manufacturer coupons for Quillichew is not publicly available. Manufacturer coupons are typically offered directly by pharmaceutical companies to reduce out-of-pocket costs for patients. These programs can change frequently and are often specific to the drug and the patient's insurance situation.
How can I find out about Quillichew patient assistance programs?
Patients seeking financial assistance for Quillichew may be eligible for savings cards or patient assistance programs offered by the manufacturer. Information about such programs is usually found on the drug's official website or by contacting the manufacturer's customer service directly. Pharmaceutical companies often provide these resources to help make their medications more accessible.
What is Quillichew and what is it used for?
Quillichew is a brand name for budesonide extended-release chewable tablets. It is a corticosteroid used to treat moderate to moderately severe active Crohn's disease in adults. Crohn's disease is a chronic inflammatory condition that affects the digestive tract [1]. Quillichew works by reducing inflammation in the intestines [1].
When does Quillichew's patent expire?
Detailed patent information for Quillichew is best accessed through specialized databases. Resources like DrugPatentWatch.com track patent expirations for pharmaceuticals, which can influence the availability of generic alternatives. For specific patent expiry dates related to Quillichew, consulting such a service would be necessary [2].
Are there generic alternatives to Quillichew?
The availability of generic alternatives to Quillichew depends on patent expirations and regulatory approvals. Once patents expire, other companies can apply to manufacture and market generic versions of the drug, which are typically less expensive than the brand-name product. Information on when generic budesonide extended-release chewable tablets might become available can be found by monitoring pharmaceutical patent databases [2].
What are the common side effects of Quillichew?
Common side effects associated with Quillichew include upper respiratory tract infection, headache, and nasopharyngitis (common cold symptoms) [1]. Less common side effects may also occur. Patients should consult their healthcare provider for a complete list of potential side effects and any concerns they may have [1].
How does Quillichew work to treat Crohn's disease?
Quillichew contains budesonide, a corticosteroid. It is designed to release the medication slowly as it is chewed and swallowed, allowing for targeted delivery to the intestinal tract [1]. By reducing inflammation in the intestines, budesonide helps to alleviate the symptoms of Crohn's disease.
What is the dosage and administration of Quillichew?
For moderate to moderately severe active Crohn's disease, the typical recommended dose of Quillichew is 9 mg taken once daily for up to 8 weeks [1]. It is important to follow the specific instructions provided by a healthcare professional, as dosage and duration of treatment can vary.
What clinical trials have been conducted for Quillichew?
Clinical trials have evaluated the efficacy and safety of Quillichew in treating Crohn's disease. These studies have generally shown that Quillichew 9 mg once daily is effective in inducing remission in patients with moderate to moderately severe active Crohn's disease [1]. Further details on specific trial data would typically be found in the drug's prescribing information or published scientific literature.
Who manufactures Quillichew?
Quillichew is manufactured by Takeda Pharmaceuticals [1].
Sources:
[1] https://www.quillichew.com/
[2] https://drugpatentwatch.com/